JPM Thematics - Genetic Therapies C2 Fonds
88,47
EUR
-0,17
EUR
-0,19
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Gilead Sciences Inc | US3755581036 | 3,55% |
| Vericel Corp | US92346J1088 | 3,55% |
| Bio-Techne Corp | US09073M1045 | 3,38% |
| Novartis AG Registered Shares | CH0012005267 | 3,32% |
| PTC Therapeutics Inc | US69366J2006 | 3,31% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,25% |
| Bristol-Myers Squibb Co | US1101221083 | 3,15% |
| Lonza Group Ltd | CH0013841017 | 3,12% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 3,01% |
| Arcellx Inc | US03940C1009 | 3,00% |
| Sonstige | 67,37% |